Table of Contents
What changed
Revenue was effectively flat at $23.3m (-0.2%) and PBT slipped only 1.1% to $8.4m, but NPAT fell 3.3% to $5.9m as the effective tax rate rose to 29.8% from 28.2%. The more material shifts sit below the P&L: operating cash flow dropped 11.0% to $5.0m, cash fell to $1.9m, and gross borrowings more than doubled to $25.0m from $11.0m, pushing net debt to $23.1m from $9.0m. Total assets expanded 26.1% to $81.7m while equity rose only 7.3% to $50.3m, confirming the balance-sheet growth was debt-funded. Container volumes were called out as down 23%. The interim dividend was held at 7.5 cents.
What matters
- Leverage inflected sharply. Net debt more than doubled against a broadly unchanged operating run-rate. Without capex disclosure in the excerpt, the driver of the $14.0m borrowing step-up is not itemised, but it is the single largest move in the release.
- Cash conversion deteriorated against flat earnings. OCF fell 11% while PBT fell just 1.1%, so the quality of this half's earnings is weaker than the headline P&L suggests.
- Forward commentary is negative on mix. Management expects bulk cargo volumes to decline in the second six months, and container volumes were already down 23% in this half – a combination that pressures the FY22 shape rather than the half just reported.
Expectations
No quantified guidance or targets were supplied. On shape, HY21 represented 56.6% of FY21 NPAT, so the prior year was first-half weighted; repeating that pattern would imply H2 NPAT materially below H1. Management's explicit warning of weaker bulk cargo in H2 reinforces that asymmetry rather than offsetting it. Annualising HY22 revenue gives $46.7m versus FY21's $47.3m – essentially a flat run-rate, but the release does not support an expectation that H2 will match H1.
Quality of result
The earnings print is more durable than it looks only at the NPAT line: PBT is the cleaner read and was down just 1.1% on flat revenue, with the NPAT gap driven by a 1.6pp higher effective tax rate rather than operating deterioration. However, cash quality weakened visibly – OCF fell 11% on flat PBT, a gap that is not explained in the provided material. ROE eased to 12.1% from 12.6% and the payout ratio against NPAT lifted slightly to 33.5%. With capex, working-capital and lease detail not disclosed here, it is not possible to tell how much of the cash shortfall is timing versus structural.
Unresolved
- What drove the $14.0m increase in gross borrowings – capex, acquisition, working capital, or dividend funding – given equity only grew $3.4m?
- Why did operating cash flow fall 11% when PBT was essentially flat? Is this a receivables/payables timing movement or a step-change?
- How large is the 23% container volume decline in revenue terms, and what offset held total revenue flat?
- With bulk cargo guided lower in H2, is the interim dividend still comfortably covered by free cash flow on a full-year basis?
This briefing cannot assess capex intensity, free cash flow, working-capital movement, or segment-level margin mix because none of those items were disclosed in the extracted material.
Key metrics
| Metric | HY22 | HY21 | Change |
|---|---|---|---|
| Revenue | $23.3m | $23.4m | -0.2% ↓ |
| Net profit after tax | $5.9m | $6.1m | -3.3% ↓ |
| Net cash inflow from operating activities | $5m | $5.6m | -11.0% ↓ |
| Final dividend per share | 7.5c | 7.5c | flat |
| Total assets | $81.7m | $64.8m | +26.1% ↑ |
Analytical metrics
| Metric | HY22 | HY21 | Context |
|---|---|---|---|
| PBT growth | -1.1% | — | cleaner earnings measure |
| Effective tax rate | 29.8% | 28.2% | — |
| Net debt | $23.1m | $9m | +$14.1m |
| Gross borrowings | $25m | $11m | +$14m |
| Payout ratio vs NPAT | 33.5% | — | — |
| ROE (annualised) | 12.1% | 12.6% | Weakening |
| HY21 share of FY21 revenue | 49.4% | — | Other half was 50.6% |
| HY21 share of FY21 NPAT | 56.6% | — | Other half was 43.4% |
| Profit from continuing operations | $5.9m | $6.1m | −$0.2m |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.
Source-backed analysis from the filing set attached to this briefing.